DE60009472D1 - Schnell dispergierende darreichungsformen, die fischgelatine enthalten - Google Patents

Schnell dispergierende darreichungsformen, die fischgelatine enthalten

Info

Publication number
DE60009472D1
DE60009472D1 DE60009472T DE60009472T DE60009472D1 DE 60009472 D1 DE60009472 D1 DE 60009472D1 DE 60009472 T DE60009472 T DE 60009472T DE 60009472 T DE60009472 T DE 60009472T DE 60009472 D1 DE60009472 D1 DE 60009472D1
Authority
DE
Germany
Prior art keywords
composition
pharmaceutical forms
forms containing
active ingredient
fast dispersing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60009472T
Other languages
English (en)
Other versions
DE60009472T2 (de
Inventor
Owen Murray
Michael Hall
Richard Green
Patrick Kearney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Publication of DE60009472D1 publication Critical patent/DE60009472D1/de
Application granted granted Critical
Publication of DE60009472T2 publication Critical patent/DE60009472T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60009472T 1999-04-08 2000-04-07 Schnell dispergierende darreichungsformen, die fischgelatine enthalten Expired - Lifetime DE60009472T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9908014 1999-04-08
GBGB9908014.5A GB9908014D0 (en) 1999-04-08 1999-04-08 Pharmaceutical compositions
PCT/US2000/009278 WO2000061117A1 (en) 1999-04-08 2000-04-07 Fast-dispersing dosage forms containing fish gelatin

Publications (2)

Publication Number Publication Date
DE60009472D1 true DE60009472D1 (de) 2004-05-06
DE60009472T2 DE60009472T2 (de) 2004-12-23

Family

ID=10851154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60009472T Expired - Lifetime DE60009472T2 (de) 1999-04-08 2000-04-07 Schnell dispergierende darreichungsformen, die fischgelatine enthalten

Country Status (28)

Country Link
US (2) US6709669B1 (de)
EP (1) EP1165053B1 (de)
JP (1) JP4838939B2 (de)
KR (1) KR100767076B1 (de)
CN (1) CN1224381C (de)
AT (1) ATE262890T1 (de)
AU (1) AU761439B2 (de)
BR (1) BR0009609A (de)
CA (1) CA2369715C (de)
CZ (1) CZ295324B6 (de)
DE (1) DE60009472T2 (de)
DK (1) DK1165053T3 (de)
ES (1) ES2215645T3 (de)
GB (1) GB9908014D0 (de)
HK (1) HK1039066B (de)
HU (1) HU229892B1 (de)
IL (2) IL145783A0 (de)
IS (1) IS2403B (de)
MX (1) MXPA01010094A (de)
NO (1) NO330196B1 (de)
NZ (1) NZ515230A (de)
PL (1) PL196572B1 (de)
PT (1) PT1165053E (de)
RO (1) RO122011B1 (de)
RU (1) RU2242969C2 (de)
TR (1) TR200102881T2 (de)
WO (1) WO2000061117A1 (de)
ZA (1) ZA200109089B (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) * 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
EP1238675A1 (de) * 2001-03-06 2002-09-11 Fuji Photo Film B.V. Rekombinante gelatineartige Proteine zur Verwendung als Plasmaexpander
EP1407677B1 (de) * 2001-07-02 2005-08-31 BIOPROGRESS S.p.A. Teilhydrolysierte Fischgelatine enthaltende Zubereitungen und deren Verwendung
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
KR100425226B1 (ko) * 2001-07-03 2004-03-30 주식회사 팜트리 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE60307082T4 (de) * 2002-05-07 2015-04-30 Ferring B.V. In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
UA93479C2 (en) * 2002-11-26 2011-02-25 Альк-Абелло A/C Allergen dosage form
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
KR101136573B1 (ko) 2003-02-28 2012-04-23 알크-아벨로 에이/에스 당류 매트릭스를 갖는 제형
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
EP2322197A2 (de) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
ATE324869T1 (de) 2003-11-13 2006-06-15 Ferring Bv Blisterverpackung und feste dosierungsform enthaltend desmopressin
US9241902B2 (en) 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
WO2006058250A2 (en) * 2004-11-24 2006-06-01 Spi Pharma, Inc. Orally disintegrating compositions
EP1835886A1 (de) * 2004-12-23 2007-09-26 Warner-Lambert Company LLC Im mund auflösende pharmazeutische zusammensetzungen mit sensorischen signalmitteln
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
KR101380147B1 (ko) 2005-05-19 2014-04-04 아쿠아 바이오 테크놀로지 에이에스에이 젤라틴 함유 국소 조성물
GB0510286D0 (en) * 2005-05-19 2005-06-29 Kilda Biolink As Composition
WO2007143674A2 (en) * 2006-06-05 2007-12-13 Verus Pharmaceuticals, Inc. Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
TW200817049A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
EP2043613A1 (de) * 2006-07-14 2009-04-08 Fmc Corporation Feste form
TWI343262B (en) * 2006-09-26 2011-06-11 Schering Corp Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
US20090214442A1 (en) * 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
US20080131508A1 (en) * 2006-12-01 2008-06-05 Cephalon, Inc Oral transmucosal nicotine dosage form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
EP2167049B1 (de) * 2007-06-04 2016-08-31 Shear/Kershman Laboratories, Inc. Manipulationssichere orale dosierform von opioid-agonisten auf lipidbasis
US20090004231A1 (en) * 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
KR100905027B1 (ko) * 2007-10-03 2009-06-30 (주)씨엘팜 식용 필름
GB2453770A (en) 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
CA2716901C (en) * 2008-02-28 2018-07-03 R.P. Scherer Technologies, Llc Process to minimize polymorphism
SI3085381T1 (en) 2008-05-21 2018-06-29 Ferring B.V. Orodispersible desmopressin to increase the initial sleep period without disturbing the nostrils
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US8420700B1 (en) * 2008-06-04 2013-04-16 James M. Bausch Tamper resistant lipid-based oral dosage form for sympathomimetic amines
WO2010017296A1 (en) * 2008-08-05 2010-02-11 Wyeth Lyophilization above collapse
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
TWI471127B (zh) 2009-04-29 2015-02-01 Intervet Int Bv 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物
US9539302B2 (en) 2009-06-18 2017-01-10 Allergan, Inc. Safe desmopressin administration
WO2011026080A1 (en) * 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
US9775819B2 (en) * 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
KR101612073B1 (ko) 2009-10-30 2016-04-14 아이엑스 바이오파마 리미티드 신속 용해 고체 투약 제형
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
PL2552418T3 (pl) 2010-03-29 2017-12-29 Ferring B.V. Szybko rozpuszczająca się kompozycja farmaceutyczna
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
KR101751964B1 (ko) * 2010-10-08 2017-06-28 알.피.쉐러 테크놀러지즈 엘엘씨 전분을 이용한 경구 백신 급속 용해성 투여 형태
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
WO2012106058A2 (en) 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
JP2011116764A (ja) * 2011-02-08 2011-06-16 Fine Seymour H 低用量デスモプレシンを含有する医薬組成物
JP6174585B2 (ja) 2011-09-16 2017-08-02 フェリング ベスローテン フェンノートシャップ 速溶性医薬組成物
EP3505159B1 (de) 2012-05-02 2020-11-04 NewMarket Pharmaceuticals LLC Pharmazeutische zusammensetzungen zur direkten systemischen einführung
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
CN107397208B (zh) * 2016-07-20 2021-05-07 吴登成 以鱼鳔胶为主成分的功能食品及其用途
MX2019004238A (es) * 2016-10-13 2019-11-08 Catalent Uk Swindon Zydis Ltd Composiciones farmaceuticas liofilizadas para suministro vaginal.
US11517533B2 (en) 2016-10-25 2022-12-06 Catalent U.K. Swindon Zydis Limited Compositions of different densities for fast disintegrating multi-layer tablet
SG10202107367SA (en) 2016-12-31 2021-08-30 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
WO2018130603A1 (en) 2017-01-11 2018-07-19 Ferring B.V. A fast disintegrating pharmaceutical composition
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
US10517834B2 (en) * 2017-05-16 2019-12-31 Owen Murray Fast dissolving tablet formulations and methods of making thereof
US20200138705A1 (en) * 2017-06-20 2020-05-07 Seattle Gummy Company Pectin gummy compostion and methods of making and using thereof
BR112020015253A2 (pt) 2018-03-08 2020-12-08 Catalent U.K. Swindon Zydis Limited Processo para reduzir endotoxina em gelatina
BR112020019396A2 (pt) 2018-03-25 2021-01-05 Biohaven Pharmaceutical Holding Company Ltd. Rimegepant para distúrbios relacionados a cgrt
SG11202011187QA (en) * 2018-05-27 2020-12-30 Biohaven Pharm Holding Co Ltd Use of riluzole oral disintigrating tablets for treating diseases
MX2020014000A (es) 2018-06-27 2021-06-15 Bioxcel Therapeutics Inc Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
EP3836922A4 (de) * 2018-08-16 2022-05-04 Biohaven Therapeutics Ltd. Verwendung von riluzol-oralen desinfektionsmitteltabletten zur behandlung von krankheiten
CA3127328A1 (en) * 2019-01-20 2020-07-23 Biohaven Pharmaceutical Holding Company Ltd. Cgrp antagonists for treating migraine breakthrough
MX2021009679A (es) 2019-02-22 2021-09-10 Catalent Uk Swindon Zydis Ltd Minimizacion de aglomeracion, aireacion y conservacion del revestimiento de composiciones farmaceuticas que comprenden ibuprofeno.
AU2020225448A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
MX2021009844A (es) 2019-02-22 2021-09-10 Catalent Uk Swindon Zydis Ltd Conservacion de particulas de ingredientes farmaceuticos activos revestidas funcionalmente producidas mediante procesos de mezcla sin solvente en suspension acuosa.
US20200268677A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
TW202220638A (zh) 2020-07-31 2022-06-01 英商康泰倫特英國斯文敦載迪斯有限公司 包含經塗覆之活性醫藥成份之醫藥組合物
CN116194085A (zh) 2020-09-17 2023-05-30 康特伦英国斯温顿捷迪斯有限公司 基于表面活性剂与高分子量鱼明胶的剂型用于改善流动特性的用途
CA3198547A1 (en) * 2020-11-16 2022-05-19 Mark RIDALL Rapidly infusing platform and compositions for therapeutic treatment in humans
US11672761B2 (en) * 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2022179634A1 (zh) * 2021-02-27 2022-09-01 北京兴源联合医药科技有限公司 一种冻干口服制剂
CA3220152A1 (en) 2021-06-11 2022-12-15 Keith FANDRICK Stabilized apilimod compositions and uses thereof
IL310591A (en) * 2021-08-19 2024-04-01 Mind Medicine Inc Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US4139497A (en) * 1977-04-04 1979-02-13 The Dow Chemical Company Dehydrogenation catalyst tablet and method for making same
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US5035896A (en) * 1988-06-15 1991-07-30 Warner-Lambert Company Water insoluble drugs coated by coacervated fish gelatin
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
IL87344A (en) 1988-08-04 1992-03-29 Univ Bar Ilan Process for the production of gelatin from fish skins
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
ATE145551T1 (de) 1989-10-02 1996-12-15 Cima Labs Inc Brausedosisform sowie verfahren zu deren verabreichung
AU650678B2 (en) 1990-08-10 1994-06-30 Analytical Control Systems, Inc. Stabilization (using gelatin from a cold water fish) of enzymes in diagnostic controls
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
DE69220080T2 (de) * 1991-10-11 1997-12-11 Abbott Lab Reagenzzusammensetzung in form von benutzer-einheiten für spezifische bindungstests
WO1993012769A1 (en) 1991-12-24 1993-07-08 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
ES2096103T3 (es) 1992-01-13 1997-03-01 Pfizer Preparacion de comprimidos de resistencia incrementada.
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
CA2166891C (en) * 1993-07-09 2001-07-03 Sang K. Wong Method for making freeze dried drug dosage forms
US5382437A (en) 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5484888A (en) 1994-03-08 1996-01-16 Holzer; David Gelatin production
US5603952A (en) * 1994-12-30 1997-02-18 Tastemaker Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
DK0893992T3 (da) * 1996-04-16 2004-06-01 Novartis Consumer Health Sa Hurtigt sönderdelende oral doseringsform
US5879796A (en) * 1996-09-05 1999-03-09 E. I. Du Pont De Nemours And Company Organic/inorganic particulates
US6071963A (en) * 1996-11-06 2000-06-06 Roche Vitamins Inc. Water dispersible compositions
KR20010005791A (ko) * 1997-04-03 2001-01-15 아베르그, 에이. 케이 벤조시클로헵타티오펜 화합물
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6077540A (en) * 1997-08-08 2000-06-20 Bayer Corporation Gelatin spray coating
US6020003A (en) * 1998-02-23 2000-02-01 Basf Corporation Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

Also Published As

Publication number Publication date
GB9908014D0 (en) 1999-06-02
PL354958A1 (en) 2004-03-22
NO330196B1 (no) 2011-03-07
RO122011B1 (ro) 2008-11-28
EP1165053B1 (de) 2004-03-31
TR200102881T2 (tr) 2002-05-21
NZ515230A (en) 2004-01-30
IS2403B (is) 2008-09-15
RU2242969C2 (ru) 2004-12-27
IS6102A (is) 2001-10-04
CA2369715C (en) 2006-03-21
CA2369715A1 (en) 2000-10-19
IL145783A0 (en) 2002-07-25
HK1039066A1 (en) 2002-04-12
US6709669B1 (en) 2004-03-23
PT1165053E (pt) 2004-06-30
CZ20013588A3 (cs) 2002-06-12
ES2215645T3 (es) 2004-10-16
JP2003524622A (ja) 2003-08-19
MXPA01010094A (es) 2002-05-06
AU761439B2 (en) 2003-06-05
US9192580B2 (en) 2015-11-24
EP1165053A1 (de) 2002-01-02
BR0009609A (pt) 2002-02-13
CN1224381C (zh) 2005-10-26
DK1165053T3 (da) 2004-06-01
HU229892B1 (en) 2014-11-28
PL196572B1 (pl) 2008-01-31
HUP0201877A3 (en) 2004-05-28
US20040076666A1 (en) 2004-04-22
CN1350450A (zh) 2002-05-22
HK1039066B (zh) 2004-08-13
JP4838939B2 (ja) 2011-12-14
CZ295324B6 (cs) 2005-07-13
DE60009472T2 (de) 2004-12-23
NO20014859D0 (no) 2001-10-05
ZA200109089B (en) 2003-04-30
KR20020000160A (ko) 2002-01-04
HUP0201877A2 (hu) 2002-11-28
ATE262890T1 (de) 2004-04-15
WO2000061117A1 (en) 2000-10-19
IL145783A (en) 2006-10-31
EP1165053A4 (de) 2002-06-12
NO20014859L (no) 2001-11-19
KR100767076B1 (ko) 2007-10-17
AU4333100A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
DE60009472D1 (de) Schnell dispergierende darreichungsformen, die fischgelatine enthalten
ATE340563T1 (de) DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
IT1246383B (it) Metodo per il mascheramento del sapore di farmaci
DK0696921T3 (da) Veterinært præparat indeholdende en protonpumpeinhibitor
RU2000100756A (ru) Способы и составы для модулирования сексуальной реакции человека
EE03805B1 (et) Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
DE69940674D1 (de) Orale verabreichung von adenosin analogen
HUP9801152A2 (hu) Nem-szteroid analgetikumok átlátszó, gyors hatóanyagkibocsátású készítményei
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
SE9700885D0 (sv) New pharmaceutical formulation
DK0615442T3 (da) Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse.
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
AP1736A (en) Oral dosage form for controlled drug release.
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
HUP9900313A1 (hu) Antiösztrogének alkalmazása hím nemzőképesség szabályozására
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
RU97109989A (ru) Способ лечения вагинозов и вагинитов у беременных
AR224929Q (es) Procedimiento para la preparacion de formas medicamentosas administrable por via oral,de liberacion uniforme e independiente del ph de una sustancia activa soluble en agua

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: R.P. SCHERER TECHNOLOGIES, INC., LAS VEGAS, NEV.,

8364 No opposition during term of opposition